key: cord-0903481-qdci9g72
authors: Brusciano, L.; Gambardella, C.; Gualtieri, G.; Tolone, S.; Lucido, F.S.; del Genio, G.; Terracciano, G.; Docimo, L.
title: SARS-CoV-2 RNA from droplets to faeces: a new focus for proctologists. Correspondence
date: 2020-06-05
journal: Int J Surg
DOI: 10.1016/j.ijsu.2020.05.087
sha: 89125dbd81cb2e98936b681150b5b3d543fef13a
doc_id: 903481
cord_uid: qdci9g72

nan

Dear Sir, since the onset of COVID-19 pandemics, our lives and sanitary systems changed to reduce contagion and permit patients' healthcare. The initial SARS-CoV-2 breakout forced the Italian Government to limit the hospital access to emergencies and oncological patients. In our proctologic outpatient clinic, during lockdown phase, pelvic floor rehabilitation appointments were canceled, and patients quality of life overshadowed. Remote consultations reduced admissions only to proctologic emergencies not showing any respiratory symptoms. Despite the suggested precautions, our physicians come in close contact with undetected asymptomatic COVID-19 patients, attending our centre for acute anal pain or bleeding. Thus, in the current reopening phase facing an increased hospital attendance, it appears crucial to screen all patients before the admittance, or, in case of unavailability of tests, to consider each patient as positive, adopting all the protective precautions of COVID-19 wards. Besides, the sudden evidence of viral RNA traces in COVID-19 patients' stool [1] long after negativity of rhino-oro-pharyngeal swab, made proctologists safety challenging in phase 2. Even if detection of viral RNA in the stool does not necessarily lead to its infectivity [2] , given the invasive and direct contact generated during digit rectal examinations and anoscopies, proctologists now, might highly require "pandemic proof" behaviors (i.e. telemedicine, use of PPE) as much as anesthesiologists and infectious disease physicians. While the infection control and surveillance until now have been focused on the respiratory system, a possible alternative and emerging scenario involving proctologist in the diagnostic and therapeutic workup might be expected in the cryptic and unpredictable COVID-19 infection.

Please specify the contribution of each author to the paper, e.g. study design, data collections, data analysis, writing. Others, who have contributed in other ways should be listed as contributors.

The Guarantor is the one or more people who accept full responsibility for the work and/or the conduct of the study, had access to the data, and controlled the decision to publish. Please note that providing a guarantor is compulsory.

Luigi Brusciano Md, PhD

COVID-19 faecal-oral transmission: Are we asking the right questions? Science of The Total Environment

Enteric involvement of coronaviruses: is faecal-oral transmission of SARS-CoV-2 possible?

Name of the registry: 2. Unique Identifying number or registration ID: 3. Hyperlink to your specific registration

The following additional information is required for submission. Please note that failure to respond to these questions/statements will mean your submission will be returned. If you have nothing to declare in any of these categories, then this should be stated.

The Authors declare they have no conflict of interests

Please enter the name of the registry, the hyperlink to the registration and the unique identifying number of the study. You can register your research at http://www.researchregistry.com to obtain your UIN if you have not already registered your study. This is mandatory for human studies only.The datasets used and/or analyzed during the current study are available from the corresponding author on reasonable request.